Audentes Therapeutics, Inc.

CIK 1628738 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Audentes Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 31, 202230000899243-22-034545
Oct 31, 2022SC 13D0001193125-22-273891
Feb 14, 2020SC 13G/A0001172661-20-000840
Feb 14, 2020SC 13G/A0001104659-20-021676
Feb 14, 2020SC 13G/A0001104659-20-021813
Feb 11, 2020SC 13G0001104659-20-016339
Feb 5, 2020SC 13G/A0000834237-20-004619
Jan 27, 202015-12B0001193125-20-014917
Jan 17, 2020EFFECT9999999995-20-000116
Jan 17, 2020EFFECT9999999995-20-000113
Jan 15, 202040001209191-20-003434
Jan 15, 202040001209191-20-003430
Jan 15, 20208-K0001193125-20-007673
Jan 15, 202040001209191-20-003426
Jan 15, 2020POSASR0001193125-20-007892
Jan 15, 2020S-8 POS0001193125-20-007870
Jan 15, 202025-NSE0001354457-20-000014
Jan 15, 2020POS AM0001193125-20-007884
Jan 15, 2020SC TO-T/A0001193125-20-007546
Jan 15, 2020POS AM0001193125-20-007888
Jan 15, 202040001209191-20-003432
Jan 15, 202040001209191-20-003431
Jan 15, 2020S-8 POS0001193125-20-007867
Jan 15, 202040001209191-20-003436
Jan 15, 202040001209191-20-003433